FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 131 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $10,251,000 | +7.7% | 272,134 | -51.4% | 0.03% | 0.0% |
| Q4 2020 | $9,516,000 | +346.6% | 559,429 | +23.4% | 0.03% | +237.5% |
| Q3 2020 | $2,131,000 | -22.2% | 453,325 | +0.9% | 0.01% | -42.9% |
| Q2 2020 | $2,740,000 | +210.7% | 449,104 | +15.6% | 0.01% | +100.0% |
| Q1 2020 | $882,000 | -59.4% | 388,378 | -18.0% | 0.01% | 0.0% |
| Q4 2019 | $2,173,000 | +212.7% | 473,401 | +163.9% | 0.01% | +250.0% |
| Q3 2019 | $695,000 | -52.2% | 179,367 | -25.6% | 0.00% | -60.0% |
| Q2 2019 | $1,453,000 | -18.7% | 241,044 | +80.7% | 0.01% | -16.7% |
| Q1 2019 | $1,788,000 | -23.8% | 133,411 | -47.1% | 0.01% | -33.3% |
| Q4 2018 | $2,345,000 | -41.2% | 252,185 | -12.0% | 0.01% | -18.2% |
| Q3 2018 | $3,990,000 | +91.4% | 286,624 | +117.3% | 0.01% | +83.3% |
| Q2 2018 | $2,085,000 | -1.8% | 131,889 | +6.7% | 0.01% | -14.3% |
| Q1 2018 | $2,123,000 | -31.4% | 123,595 | -12.5% | 0.01% | -30.0% |
| Q4 2017 | $3,097,000 | +119.8% | 141,268 | +262.5% | 0.01% | +100.0% |
| Q1 2017 | $1,409,000 | +263.1% | 38,968 | +427.6% | 0.01% | +400.0% |
| Q3 2016 | $388,000 | +22.0% | 7,386 | -3.9% | 0.00% | 0.0% |
| Q2 2016 | $318,000 | -92.4% | 7,685 | -92.6% | 0.00% | -95.0% |
| Q1 2016 | $4,192,000 | +278.7% | 103,169 | +112.9% | 0.02% | +300.0% |
| Q1 2015 | $1,107,000 | – | 48,448 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|